Financing, Pharma

Life science deals $39.3M financing for Celator

Posted on 01 May 2013

Tags: , , ,

Life science deals financing has raised $32.5 million in the final closing of a private placement of common stock and warrants to purchase common stock for Celator.

Proceeds totaling $39.3 million, including $6.8 million from prior closings, have been raised in this life science deals financing and will support the late-stage clinical development of the Company's lead investigational product, CPX-351 Liposome Injection.

The product is used in the Oncology area for the treatment of Acute Myelogenous Leukemia.

This life science deals financing is expected to fully fund the Company's currently enrolling Phase 3 clinical study as first-line therapy in patients, 60-75 years of age, with secondary acute myeloid leukemia.

Daily news stories                                                                           

For further deal information visit Current Agreements (subscription required)

Related

Report: Leukemia Partnering

Report: Oncology Partnering Terms and Agreements

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply